The 20 Most Interesting Ideas We've Found in 2026

· Source: ChinaTalk · Field: Government & Public Sector — Public Policy & Governance, International Relations & Diplomacy, Public Safety & Security · Depth: Intermediate, extended

Summary

ChinaTalk's "20 Most Interesting Ideas We've Found in 2026" reveals key geopolitical and technological insights. Xi Jinping's purges suggest confidence regarding Taiwan, influenced by perceived US disinterest and KMT shifts. Chinese developers are bypassing Claude restrictions, using discounted tokens to train domestic AI models, yet top Chinese AI leadership remains pessimistic about catching up to US closed models. China holds an estimated 2.7–2.8 million H100-equivalent GPUs, about one-eighth of global AI compute, but US export controls are effective, as networking limits prevent quantity from substituting for quality. The US is advised to buy Chinese commodity DRAM to reduce China's HBM capacity. China's AI adoption is driven by job displacement fears, not optimism, and its AI-in-education initiative risks becoming a surveillance-heavy boondoggle. China's biotech dominance, exemplified by WuXi AppTec, is structurally entrenched, and its clinical trial system fosters rapid medical innovation.

Key takeaway

For Policy Makers addressing US-China tech competition and supply chain resilience, you must recognize that export controls, while impacting quality, face sophisticated circumvention. Your critical resource strategy needs to shift from broad categories to targeted investments based on specific interference risks, such as GOES and gallium, to maximize impact. Additionally, consider China's structural advantages in power grids and biotech, and explore unconventional solutions like buying Chinese commodity DRAM to influence their HBM capacity.

Key insights

China's strategic confidence and technological pursuits face internal challenges and external policy impacts.

Principles

Method

Individual doctors in China can initiate clinical trials with real patients without centralized approval, relying on reputation and trust for safety and collaboration.

In practice

Topics

Best for: CTO, VP of Engineering/Data, Director of AI/ML, Policy Maker, Investor, Consultant

Related on AIssential

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by ChinaTalk.